Enzymatic transhydrogenation reactions involving pyridine nucleotides have been described in bacteria (2), beef heart (3), rat and rabbit tissues (4), human placenta (5), and spinach (6). TD A previous study from this laboratory (8) on the pyridine nucleotides of human leukocytes revealed a marked elevation of the DPN content of leukemic cells. Because of this finding, a further examination has been made of various enzymes responsible for the interconversion of pyridine nucleotides. The present report describes the identification, characterization, and levels of the two pyridine nucleotide transhydrogenases in the leukocytes of normal subjects and various leukemia patients.
The asterisk in Equation 2 indicates a labeled DPN molecule or a DPN analogue to distinguish between the two components.
A previous study from this laboratory (8) on the pyridine nucleotides of human leukocytes revealed a marked elevation of the DPN content of leukemic cells. Because of this finding, a further examination has been made of various enzymes responsible for the interconversion of pyridine nucleotides. The present report describes the identification, characterization, and levels of the two pyridine nucleotide transhydrogenases in the leukocytes of normal subjects and various leukemia patients.
METHODS
The following materials were used: DPNH, TPNH. and protamine sulfate; 3 3-acetylpyridine-DPN, 3-pyridine aldehyde-DPN, 3-acetylpyridine-deamino-DPN, and thionicotinamide-DPN; 4 EDTA; 5 thyroxine and 3'5'-triiodothyronine; 6 17-,8-estradiol, diethylstilbesterol, and androsterone; 7 and 3-acetylpyridine-TPN. 8 Clinical material for this study was selected according to the criteria used in the preceding paper (9) . In general, cells from leukemia patients were obtained before treatment, except that two of the chronic myelocytic leukemia patients were being treated with busulfan and four of the chronic lymphocytic leukemia patients were receiving chlorambucil at the time of sampling. The leukocyte counts and enzyme levels of these treated patients, however, were comparable to those of untreated patients in the same clinical categories, and the data are included, therefore, in this paper. Leukocytes were isolated from whole blood by the procedure described previously (8, 9) . Enzyme assays were performed on cell lysates prepared as follows: The isolated leukocytes were suspended in 0.08 M phosphate buffer, pH 7.5, and homogenized for 3 minutes at 45,000 rpm in a Virtis "45" homogenizer (4-to 15-ml cup). (4) . For the assay of DD transhydrogenase, the reaction mixture contained 100 Asmoles of potassium phosphate buffer, pH 7.5, 1.5 jimoles of sodium cyanide, 0.2,mole of DPNH, 0.2 jmole of 3-acetylpyridine-DPN, and the enzyme (1 to 3 mg of protein) in a total volume of 1.0 ml. For the assay of TD transhydrogenase, the components were the same except that pH 6.5 phosphate buffer was used, TPNH was substituted for DPNH, and 10 /moles of EDTA was added. In both reactions, the increase in absorbancy at 375 m/ was determined over a 5-minute period and corrected for blank reactions in which a) the pyridine nucleotide analogue was omitted and b) the reduced pyridine nucleotide was omitted. The control reactions were less than 10%o of the complete reaction. A millimo!ar extinction coefficient of 5.1 was used to calculate concentration changes in the above reactions (4 (Table  I ). The inhibition of DD transhydrogenase by Cd++ was reversed by the dithiol, 2,3-dimercapto-1-propanol, whereas the monothiols, cysteine and glutathione, were ineffective even when present at a concentration five times greater than that of the dithiol. Both the DD and TD enzymes were inhibited about 50%o by pCMB at 5 X 10-4 M, and in both cases, the inhibition could be reversed by the addition of cysteine.
The results of experiments concerned with the effect of certain hormones on the leukocyte DD and TD transhydrogenases showed that the latter enzyme was inhibited about 30%o by thyroid hormones (1-thyroxine and 3',5'-triiodothyronine) at a concentration of 10-4 M, whereas the activity of the DD enzyme was not altered under these conditions. On the other hand, neither of the enzymes was affected by estrogens or androgens, such as 17-p-estradiol (3 ug per ml), a commercial preparation (Premarin) of conjugated estrogens (30 ug per ml), diethylstilbestrol (10-4 M), and androsterone (10-4 M).
The relative activities of the leukocyte DD and TD transhydrogenases were studied with several pyridine nucleotide analogues that replaced DPN and DPN,* respectively, as the oxidants in Reactions 1 and 2. The analogues differed from DPN in terms of the substituent groups at the 3 position of the pyridine ring or at the 6 position of the adlenine moiety. The data for the activities of these analogues with the two transhydrogenases are presented in Table II . When the activity with 3-acetylpyridine-DPN is set arbitrarily at 100, decreased rates in both enzyme systems were noted when the analogue was changed by 1) deamination of the adenine, 2) replacement of the acetyl group with an aldehyde, or 3) addition of a third phosphate to give 3-acetylpyridine-TPN. Replacement of the 3-acetyl group by a thioamide group, as in thionicotinamide-DPN, however, enhanced the rate of the DD enzyme, but caused a decrease in the acivity of the TD enzyme.
Levels of DD and TD transhydrogenases in normal and leukemic leukocytes. The levels of both transhydrogenase enzymes were determined in 25 normal subjects and in 25 patients with leukemia (Table III) .9 The DD transhydrogenase 9 Using a different assay than the one employed here, Evans and Karnovsky (10) Since the Cd++ inhibition of DD transhydrogenase can be reversed by dithiols, but not by monothiols, it is likely that vicinal dithiol groups are involved in the mechanism of action of this enzyme, which thus resembles its counterpart in beef heart mitochondria (3). The leukocyte enzymes are unique, however, among transhydrogenases insofar as their pH optima are about 2 pH U lower than usual.
Evidence that two separate enzymes are involved in Reactions 1 and 2 is provided by the following observations: 1) TD activity is lost during the purification procedure for the DD activity; 2) Cd++ at 5 X 10-4 M inhibits the DD activity, but does not alter TD activity; 3) DD transhydrogenase is more active with thionicotinamide-DPN as a substrate than with 3-acetylpyridine-DPN, whereas the converse relationship obtains for the TD enzyme; and 4) thyroid hormones inhibit TD transhydrogenase, but not DD transhydrogenase. similar pH optimum and Km values like those of the transhydrogenase described above.
Although various transhydrogenases have been reported to be affected by thyroid hormones (7) and by certain steroid hormones (5), the leukocyte enzymes are relatively insensitive to these agents. The TD transhydrogenase is partially inhibited by thyroxine or triiodothyronine, but only when these hormones are present at 10-4 M, and the in vivo significance of this finding is doubtful.
None of the steroid hormones tested had any effect on either leukocyte transhydrogenase activity.
The finding that the level of TD transhydrog- 2 2) The pH optima for the DD and TD transhydrogenases are 5.8 and 6.3, respectively. At their optima, the relative activity of the DD enzyme is about 3 times that of the TD enzyme.
3) Both transhydrogenases are inhibited about 50%o by p-chloromercuribenzoate at 5 x 10-4 M, and the inhibitions are reversed by the addition of thiols. Cd++ at 5 X 10-4 M inhibits the DD enzyme about 65%, but does not affect the TD enzyme; this inhibition is reversed by dithiols but not by monothiols.
4) Thyroxine and triiodothyronine at 10-4 M inhibit the TD enzyme by about 30%, but do not affect the DD enzyme. Steroid hormones do nlot affect either transhydrogenase. 5) Levels of the two transhydrogenases have been determined in 25 normal subjects and in 25 patients with leukemia. The level of the DD enzyme is 2 to 4 times higher than that of the TD enzyme in both normal and leukemic cells. The level of the TD transhydrogenase is 3 to 4 times higher than normal in acute and chronic lymphocytic leukemic cells and slightly higher than normal in chronic myelocytic cells. The level of the DD enzyme is elevated slightly above normal in the leukemic cells.
